Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study

Background. Little is known about the role of cytokeratin 17 (CK17) during oral carcinogenesis. CK17 expression in oral leukoplakia (OL), the most encountered oral potentially malignant disorders and oral squamous cell carcinoma (OSCC), remains very limited. To determine the role of CK17 during oral...

Full description

Saved in:
Bibliographic Details
Main Authors: Sirima Sanguansin, Theerachai Kosanwat, Rachai Juengsomjit, Sopee Poomsawat
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Dentistry
Online Access:http://dx.doi.org/10.1155/2021/4089549
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566617406439424
author Sirima Sanguansin
Theerachai Kosanwat
Rachai Juengsomjit
Sopee Poomsawat
author_facet Sirima Sanguansin
Theerachai Kosanwat
Rachai Juengsomjit
Sopee Poomsawat
author_sort Sirima Sanguansin
collection DOAJ
description Background. Little is known about the role of cytokeratin 17 (CK17) during oral carcinogenesis. CK17 expression in oral leukoplakia (OL), the most encountered oral potentially malignant disorders and oral squamous cell carcinoma (OSCC), remains very limited. To determine the role of CK17 during oral carcinogenesis and its potential diagnostic marker in oral premalignant and malignant lesions, this study evaluated CK17 expression in OL without dysplasia, OL with dysplasia, and OSCC. CK17 expression in these tissues was compared with those of normal oral mucosa (NOM). Additionally, the relationship between CK17 expression and clinicopathologic factors of OSCC was investigated. Methods. CK17 expression was evaluated in 186 samples consisting of 12 NOM, 33 OL without dysplasia, 58 OL with dysplasia, and 83 OSCC using immunohistochemistry. The proportion of positively immunostained cells was evaluated and scored. Results. CK17 was expressed in 8.3%, 54.5%, 74.1%, and 90.4% of NOM, OL without dysplasia, OL with dysplasia, and OSCC, respectively. NOM had a significantly lower CK17 score than OL with dysplasia (p=0.0003) and OSCC (p<0.0001). A significant association between CK17 expression and histopathologic differentiation of OSCC was found. Tumors with well differentiation had high CK17 expression compared with those of moderate and poor differentiation. Conclusion. CK17 was overexpressed in OL with dysplasia and OSCC, suggesting that CK17 plays a pivotal role in the development of premalignant lesions and OSCC. Of clinical significance, CK17 may be a good diagnostic marker for oral premalignant lesions and OSCC. Additionally, CK17 could be used as an objective tool to classify histopathologic grade in OSCC. The findings that CK17 expression is high in OSCC but low in NOM imply that CK17 may serve as a potential therapeutic target for OSCC.
format Article
id doaj-art-65ef47ad08464edbbb02c7e0cba4b66f
institution Kabale University
issn 1687-8736
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Dentistry
spelling doaj-art-65ef47ad08464edbbb02c7e0cba4b66f2025-02-03T01:03:41ZengWileyInternational Journal of Dentistry1687-87362021-01-01202110.1155/2021/4089549Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical StudySirima Sanguansin0Theerachai Kosanwat1Rachai Juengsomjit2Sopee Poomsawat3Department of Oral BiologyDepartment of Oral and Maxillofacial PathologyDepartment of Oral and Maxillofacial PathologyDepartment of Oral and Maxillofacial PathologyBackground. Little is known about the role of cytokeratin 17 (CK17) during oral carcinogenesis. CK17 expression in oral leukoplakia (OL), the most encountered oral potentially malignant disorders and oral squamous cell carcinoma (OSCC), remains very limited. To determine the role of CK17 during oral carcinogenesis and its potential diagnostic marker in oral premalignant and malignant lesions, this study evaluated CK17 expression in OL without dysplasia, OL with dysplasia, and OSCC. CK17 expression in these tissues was compared with those of normal oral mucosa (NOM). Additionally, the relationship between CK17 expression and clinicopathologic factors of OSCC was investigated. Methods. CK17 expression was evaluated in 186 samples consisting of 12 NOM, 33 OL without dysplasia, 58 OL with dysplasia, and 83 OSCC using immunohistochemistry. The proportion of positively immunostained cells was evaluated and scored. Results. CK17 was expressed in 8.3%, 54.5%, 74.1%, and 90.4% of NOM, OL without dysplasia, OL with dysplasia, and OSCC, respectively. NOM had a significantly lower CK17 score than OL with dysplasia (p=0.0003) and OSCC (p<0.0001). A significant association between CK17 expression and histopathologic differentiation of OSCC was found. Tumors with well differentiation had high CK17 expression compared with those of moderate and poor differentiation. Conclusion. CK17 was overexpressed in OL with dysplasia and OSCC, suggesting that CK17 plays a pivotal role in the development of premalignant lesions and OSCC. Of clinical significance, CK17 may be a good diagnostic marker for oral premalignant lesions and OSCC. Additionally, CK17 could be used as an objective tool to classify histopathologic grade in OSCC. The findings that CK17 expression is high in OSCC but low in NOM imply that CK17 may serve as a potential therapeutic target for OSCC.http://dx.doi.org/10.1155/2021/4089549
spellingShingle Sirima Sanguansin
Theerachai Kosanwat
Rachai Juengsomjit
Sopee Poomsawat
Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
International Journal of Dentistry
title Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
title_full Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
title_fullStr Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
title_full_unstemmed Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
title_short Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study
title_sort diagnostic value of cytokeratin 17 during oral carcinogenesis an immunohistochemical study
url http://dx.doi.org/10.1155/2021/4089549
work_keys_str_mv AT sirimasanguansin diagnosticvalueofcytokeratin17duringoralcarcinogenesisanimmunohistochemicalstudy
AT theerachaikosanwat diagnosticvalueofcytokeratin17duringoralcarcinogenesisanimmunohistochemicalstudy
AT rachaijuengsomjit diagnosticvalueofcytokeratin17duringoralcarcinogenesisanimmunohistochemicalstudy
AT sopeepoomsawat diagnosticvalueofcytokeratin17duringoralcarcinogenesisanimmunohistochemicalstudy